Cover Image
市場調查報告書

EpiCast Report:慢性腎臟病 (CKD)的流行病學的預測

EpiCast Report: Chronic Kidney Disease - Epidemiology Forecast to 2026

出版商 GlobalData 商品編碼 595459
出版日期 內容資訊 英文 32 Pages
訂單完成後即時交付
價格
Back to Top
EpiCast Report:慢性腎臟病 (CKD)的流行病學的預測 EpiCast Report: Chronic Kidney Disease - Epidemiology Forecast to 2026
出版日期: 2017年12月01日 內容資訊: 英文 32 Pages
簡介

本報告提供全球主要7個國家 (美國、法國、德國、義大利、西班牙、英國、日本) 的,慢性腎臟病 (CKD、慢性腎衰竭)的市場趨勢和今後預測相關分析,目前患病人數和發病情形 (各年齡、男女等),今後10年的患病數量的預測值等調查。

第1章 目錄

第2章 慢性腎臟病 (CKD):摘要整理

第3章 流行病學

  • 疾病的背景情況
  • 風險要素和共生病症
  • 全球各國的過去趨勢
  • 預測手法
    • 資訊來源
    • 預測的前提條件與手法
  • 慢性腎臟病 (CKD):流行病學的預測 (今後11年份)
    • CKD的患病者總數:病期I∼IV
    • 各年齡的患病人數:病期I∼IV
    • 男女的患病人數:病期I∼IV
    • 各病期的患病人數
    • CKD的已受診患病人數:病期I∼V
    • CKD的已受診患病人數:各病期
  • 討論
    • 流行病學預測相關考察
    • 分析的限制
    • 分析的優勢

第4章 附錄

目錄
Product Code: GDHCER175-17

Chronic kidney disease (CKD), or chronic renal disease, is an asymptomatic, long-term condition that damages the kidneys and leads to the loss of kidney function over time (NIH, 2010). As the disease progresses, the symptoms worsen, eventually leading to kidney failure (NIH, 2010). The glomerular filtration rate (GFR), a key measure of kidney function, is determined by the amount of creatinine in the blood, and the Kidney Disease, Improving Global Outcomes (KDIGO) classification system is considered the standard for GFR measurement and diagnosis of CKD.

CKD affects people of all ages, but the risk is higher in those ages 65 years and older. Globally, the estimated prevalence of CKD is around 7% in people over the age of 30 years (Zhang and Rothenbacher, 2008). In addition, CKD is more common in women thanmen, and is also more common in people of African and South Asian origin due to the high prevalence of diabetes in South Asians and hypertension in people of African origin.

In the 7MM, our epidemiologists forecast the diagnosed prevalent cases of CKD, Stages I-V, to increase from around 25.7 million cases in 2016 to over 28.3 million cases in 2026, at an Annual Growth Rate (AGR) of almost 1%. The UK will have the highest number of diagnosed cases of CKD throughout the forecast period.

The report "EpiCast Report: Chronic Kidney Disease - Epidemiology Forecast to 2026", provides an overview of the risk factors, comorbidities, and the global and historical trends of CKD in the seven major markets (7MM) (US, France, Germany, Italy, Spain, UK, and Japan). It also includes a 10-year epidemiological forecast for the total prevalent cases of CKD, Stages I-IV, segmented by age (beginning at 20 years and ending at ages 80 years and older), by sex, and by stage. Furthermore, this report includes a forecast of the diagnosed prevalent cases of CKD, Stages I-V, and the diagnosed prevalent cases of CKD by stage.

Scope

  • The Chronic Kidney Disease EpiCast Report provides an overview of the risk factors and global trends of chronic kidney disease in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).
  • This report also includes a 10-year epidemiological forecast for the total prevalent cases of CKD, Stages I-IV, segmented by age (beginning at 20 years and ending at ages 80 years and older), by sex, and by stage. Furthermore, this report includes a forecast of the diagnosed prevalent cases of CKD, Stages I-V, and the diagnosed prevalent cases of CKD by stage.
  • The chronic kidney disease epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
  • The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

Reasons to buy

The Chronic Kidney Disease EpiCast report will allow you to -

  • Develop business strategies by understanding the trends shaping and driving the global chronic kidney disease treatment market.
  • Quantify patient populations in the chronic kidney disease market to improve product design, pricing, and launch plans.
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for chronic kidney disease therapeutics in each of the markets covered.
  • Understand magnitude of chronic kidney disease.

Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 3
  • 1.2 List of Figures 3

2 Chronic Kidney Disease: Executive Summary 4

  • 2.1 Related Reports 5
  • 2.2 Upcoming Reports 6

3 Epidemiology 7

  • 3.1 Disease Background 7
  • 3.2 Risk Factors and Comorbidities 8
  • 3.3 Global and Historical Trends 8
  • 3.4 Forecast Methodology 9
    • 3.4.1 Sources 10
    • 3.4.2 Forecast Assumptions and Methods 14
  • 3.5 Epidemiological Forecast for CKD (2016-2026) 20
    • 3.5.1 Total Prevalent Cases of CKD, Stages I-IV 20
    • 3.5.2 Age-Specific Total Prevalent Cases of CKD, Stages I-IV 20
    • 3.5.3 Sex-Specific Total Prevalent Cases of CKD, Stages I-IV 21
    • 3.5.4 Total Prevalent Cases of CKD by Stage 22
    • 3.5.5 Diagnosed Prevalent Cases of CKD, Stages I-V 23
    • 3.5.6 Diagnosed Prevalent Cases of CKD by Stage 24
  • 3.6 Discussion 25
    • 3.6.1 Epidemiological Forecast Insight 25
    • 3.6.2 Limitations of the Analysis 26
    • 3.6.3 Strengths of the Analysis 26

4 Appendix 27

  • 4.1 Bibliography 27
  • 4.2 About the Authors 29
    • 4.2.1 Epidemiologists 29
    • 4.2.2 Reviewers 29
    • 4.2.3 Global Director of Therapy Analysis and Epidemiology 30
    • 4.2.4 Global Head and EVP of Healthcare Operations and Strategy 31
  • 4.3 About GlobalData 32
  • 4.4 Contact Us 32
  • 4.5 Disclaimer 32

List of Tables

  • Table 1: KDIGO Classification of CKD 7
  • Table 2: Risk Factors and Comorbidities for CKD 8
  • Table 3: 7MM, Total Prevalent Cases of CKD, Stages I-IV, Both Sexes, Ages ≥20 Years, N, Selected Years from 2016-2026 20
  • Table 4: 7MM, Diagnosed Prevalent Cases of CKD, Stages I-V, Both Sexes, Ages ≥20 Years, N, Selected Years from 2016-2026 24

List of Figures

  • Figure 1: 7MM, Diagnosed Prevalent Cases of CKD, Stages I-V, Both Sexes, Ages ≥20 Years, N, 2016 and 2026 5
  • Figure 2: 7MM, Age-Standardized Total Prevalence of CKD, Stages I-IV, Ages ≥20 Years, 2016 9
  • Figure 3: 7MM, Sources Used to Forecast the Total Prevalent Cases of CKD Stages I-IV 10
  • Figure 4: 7MM, Sources Used to Forecast the Total Prevalent Cases of CKD by Stage 11
  • Figure 5: 7MM, Sources Used to Forecast the Diagnosed Prevalent Cases of CKD Stages I-IV 12
  • Figure 6: 7MM, Sources Used to Forecast the Number of CKD Cases on Dialysis 13
  • Figure 7: 7MM, Sources Used to Forecast the Number of New Kidney Transplants 14
  • Figure 8: 7MM, Age-Specific Total Prevalent Cases of CKD, Stages I-IV, Both Sexes, Ages ≥20 Years, N, 2016 21
  • Figure 9: 7MM, Sex-Specific Total Prevalent Cases of CKD, Stages I-IV, Both Sexes, Ages ≥20 Years, N, 2016 22
  • Figure 10: 7MM, Total Prevalent Cases of CKD by Stage, Both Sexes, Ages ≥20 Years, N, 2016 23
  • Figure 11: 7MM, Diagnosed Prevalent Cases of CKD by Stage, Both Sexes, Ages ≥20 Years, N, 2016 25
Back to Top